Best NAD+ Providers in 2026 — Ranked & Reviewed
Energy, cellular repair and cognitive support are the usual reasons NAD+ is prescribed, usually by subcutaneous injection, and increasingly by nasal spray or in an oral liposomal form. Of every peptide in our catalog it is the one most widely offered. No FDA-approved finished drug exists for it; compounding pharmacies dispense it instead, which puts sourcing and clinical oversight squarely in the hands of whichever provider you pick. Every clinic below works through a licensed provider, and all are scored on the six dimensions used across this site.
Lowest verified price: $93/mo139 providers compared
New to NAD+? Read our full NAD+ guide — evidence, dosing, safety and side effects.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
139 nad+ providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
knowing which pharmacy fills the vial — it names RedRock Pharmacy
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin - Best Budget
semaglutide at $99/month, 48% under the register median
From /mo$93Coverage50 statesMedicationsNAD+Sermorelin - Nationwide Coverage
starting below a standard dose, with microdose tiers
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin semaglutide at $99/month, 48% under the register median
From /moCheck pricingCoverage50 statesMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinMOTS-cNAD+TB-500Tesamorelinsemaglutide at $99/month, 48% under the register median
From /moCheck pricingCoverage50 statesMedicationsNAD+semaglutide at $105/month, 44% under the register median
From /moCheck pricingCoverage42 statesMedicationsNAD+Sermorelinmoving between compounded and brand without changing seller
From /moCheck pricingCoverage50 statesMedicationsNAD+Sermorelinknowing which pharmacy fills the vial — it names Tru Meds Rx
From /moCheck pricingCoverage39 statesMedicationsNAD+
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick knowing which pharmacy fills the vial — it names RedRock Pharmacy | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
Best Budget semaglutide at $99/month, 48% under the register median | $93 | NAD+Sermorelin | 50 states | Visit → | |
Nationwide Coverage starting below a standard dose, with microdose tiers | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
 semaglutide at $99/month, 48% under the register median | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinMOTS-cNAD+TB-500Tesamorelin | 50 states | Visit → | |
 semaglutide at $99/month, 48% under the register median | Check pricing | NAD+ | 50 states | Visit → | |
 semaglutide at $105/month, 44% under the register median | Check pricing | NAD+Sermorelin | 42 states | Visit → | |
 moving between compounded and brand without changing seller | Check pricing | NAD+Sermorelin | 50 states | Visit → | |
 knowing which pharmacy fills the vial — it names Tru Meds Rx | Check pricing | NAD+ | 39 states | Visit → |
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
Detailed Reviews
About the prices below: every dollar figure inside these provider summaries belongs to that clinic’s GLP‑1 weight-loss program. None is a NAD+ price. For NAD+ itself, read the figure next to each clinic in the comparison table above, taken from the clinic’s own product page. A reading of “Check pricing” means the clinic does prescribe NAD+ and publishes nothing for it, so you are quoted after your consultation.
Embody
Best for: knowing which pharmacy fills the vial — it names RedRock Pharmacy
Embody sells compounded semaglutide and tirzepatide by injection, plus a compounded oral tirzepatide gum that is unique in the category. Flat-rate pricing is aggressive, coverage runs to all 50 states, and clinician messaging is available 24/7 under a board-certified internal medicine CMO.
Score Breakdown
Pros
- ✓Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $129 a month, 52% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓Names 4 dispensing pharmacies, which most sellers in this register do not do
- ✓No FDA warning letter matched this operator when we searched our enforcement register
- ✓Both oral and injectable options are on record, so the format is a choice rather than a condition
Cons
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
CoreAge Rx
Verified partnerBest for: semaglutide at $99/month, 48% under the register median
Shipping is free, 2-day, and reaches all 50 states. CoreAge Rx sells LegitScript-verified compounded semaglutide plus tirzepatide, with licensed physicians behind it and 24/7 support. Its own claim: nobody in the compounded GLP-1 space prices more competitively.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $149 a month, 44% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
bmiMD
Best for: starting below a standard dose, with microdose tiers
bmiMD is a medical weight loss clinic that prescribes GLP-1 medications through telehealth.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $139 a month, 48% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Live Vital
Verified partnerBest for: semaglutide at $99/month, 48% under the register median
Billed in 3-month blocks, the compounded GLP-1 semaglutide starts at $99/mo and compounded tirzepatide at $183/mo. Dr. Patrick Taylor, MD founded the practice and every plan is written by a doctor, filled at a licensed US pharmacy and delivered to the door. Messaging the care team has no cap and nothing locks you in. Peptide and hormone therapy round out the menu. Telehealth reaches all 50 states.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $183 a month, 31% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its retatrutide and semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Fresh Day Meds
Best for: semaglutide at $99/month, 48% under the register median
Fresh Day Meds starts compounded semaglutide at $133/mo and tirzepatide at $166/mo on the 3-month plan, among the lowest in the segment. The Houston-based, LegitScript-certified platform folds the consultation fee into the medication price, ships free, and says prescription review takes under four hours. Hair, sexual-wellness, testosterone and daily-wellness products sit on the same account.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $140 a month, 48% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication and shipping
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Comparing NAD+ sellers
No peptide-adjacent therapy appears on more telehealth menus than NAD+. It reaches buyers as a subcutaneous injection, as an IV infusion, as oral precursors, and as a nasal spray. Those four are distinct products at distinct prices, and a list that mixes them says very little.
What to check
- The route changes the dose and the bill. At home, the usual form is a subcutaneous injection. An IV infusion is given in a clinic and costs a great deal more. Nasal products and the oral precursors NR and NMN are supplements rather than the compounded drug. Deciding the route comes before reading any price.
- Milligrams per vial, then price. Two clinics can advertise an identical monthly price against very different strengths. Milligrams per vial, and vials per month, are what turn a price into something comparable.
- How the evidence gets described. Mechanistic support for this molecule is genuine and the clinical-outcome evidence is thin. Presented as proven anti-aging therapy, it has been oversold by the seller. Sites drawing a line between what is established and what is not are describing the same compound accurately.
Red flags
- Vials sold with no prescriber involved. A vial marked 'not for human consumption' and sold 'for research use only' sits outside the drug approval system, where identity, purity and sterility are nobody's stated responsibility. In the US, every peptide on this page needs a prescription. Where no licensed clinician writes one, the product is not the one described here.
- The 503A or 503B pharmacy is never named. No finished product for these peptides carries FDA approval, which leaves compounding as the only lawful route to a dose. Plenty of clinics name the pharmacy behind the vial. Where a clinic does not, the supply chain ends at its own claim.
- 'FDA-approved' attached to a compounded peptide. Compounding does not bring FDA approval with it, and a seller saying otherwise has committed a marketing violation rather than a slip of wording. A few of these molecules did hold an approval once, under a discontinued brand and for a separate indication. That history says nothing about the compounded vial on sale now.
- Results promised with no trial behind them. For most molecules in this category the evidence is mechanistic or early phase; randomized outcome trials are rare. A clinic promising a defined outcome for fat loss, for muscle, or for anti-aging has moved past what the literature carries. Our evidence review for each molecule sets out what exists.
- IGF-1 never drawn on a hormone-axis peptide. Raising IGF-1 is what a growth-hormone secretagogue is for, and it is also the number that shows when a dose has gone too far. A clinic measuring it at neither baseline nor follow-up has no way to tell those two states apart.
Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- 503A pharmacy · Pharmacy and drug forms
- 503A vs 503B (pharmacy compounding) · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.